Duke University Medical Center DUMC

Durham, North Carolina 27710

3 studies enrolling now · 19 studies all time

What they study most

AML, Advanced Solid Tumor, Atrial Fibrillation, CIED Related Infection, Cardiovascular Disease, Congestive Heart Failure, Deep Vein Thrombosis, General Anesthesia, Heart Failure, Heart Failure With Left Bundle Branch Block, Hematologic Malignancies, Hepatic Impairment

Studies at this site

• PULSED AF Post-Approval Study — Recruiting now
• A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors — Recruiting now
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Extravascular ICD Pivotal Study — Completed
• AdaptResponse Clinical Trial — Completed
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma — Stopped early
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
• Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism — Completed
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis — Stopped early
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn — Completed
• Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function — Completed
• Attain Stability™ Quad Clinical Study — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• MIRACLE EF Clinical Study — Stopped early
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery — Stopped early
• A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies — Completed